Year End Report May 1, 2024 – April 30, 2025

• Net sales amounted to 3 203 354 SEK (1 510 872).
• Operating loss (EBIT) amounted to - 8 417 903 SEK (- 9 359 701).
• Loss after financial items amounted to till – 16 729 266 SEK (- 9 767 787) where wite down in investment portfolio was 11 690 334 SEK.
• Loss after tax amounted to - 16 729 266 SEK (-9 767 786).
• Earnings per share amounted to - 0,14 SEK (-0,52).
• Solvency in the group was 94% (95).

Interim Report November 1, 2024 – April 30, 2025

• Net sales amounted to 1 539 392 SEK (881 659).
• Operating loss (EBIT) amounted to - 4 132 039 SEK (-4 024 383).
• Loss after financial items amounted to - 15 485 337 SEK (- 4 814 435).
• Loss after tax amounted to - 15 485 337 SEK (- 4 814 435).

Significant events during the period November1, 2024 – April 30, 2025

• January 2, Patric Sjölund takes over as acting CEO.
• January 16, an agreement is signed to acquire all shares in Healthy to 100 AS.
• In February, NGM approves the relisting, as a result of the reverse acquisition, of H100 Group AB.
• On March 7, an extraordinary general meeting approves the reverse acquisition of Healthy to 100 AS.
• The acquisition of Healthy to 100 AS is completed on April 7, and Sander Andersen takes over as the new CEO for the H100 Group.
• From April 23, the company’s shares are traded under the name H100.
• On April 24, H100 Group enters into an agreement with Epivity Health and Livity as users of the H100 platform for e-health.

Significant events after Year End April 30, 2025

• On May 16 H100 announces the launch of its Global Health Initiative.
• The first bitcoin investment is done May 22.
• On May 25 H100 secures 21 MSEK in a convertible loan facility led by Adam Back.
• H100 Group Enters into Introducing Agreement with Finpeers SA.
• On June 3 preliminary figures for the year 2024/2025 is released.
• H100 Group secures another 21 MSEK convertible loan commitment from Adam Back, with a right to invest up to an additional 128 MSEK with a contemplated total size of 277 MSEK.
• On June 9, H100 Group Secures 28.4 MSEK Across Convertible Loan and Share Issue.

CEO Statement
Shareholders in H100 Group AB,
The operating year 2024/2025 has come to an end, marking a transformative chapter for both the company and our shareholders. The journey began with a letter of intent in August 2024, culminating in the acquisition of 100% of Health to 100 AS by eBlitz Group in April 2025 — and the formal creation of H100 Group. Now, we begin writing a new chapter in health history.

Our Vision
H100 exists to support health and longevity service providers with AI-powered automation, business growth tools, and seamless integration — allowing them to focus on what matters: helping their clients thrive to 100. Our Global Health Initiative is built to serve the sovereign individual — internet-native, privacy-conscious, and proactive in health. We believe this is a highly underserved segment and a clear strategic gap in the global market.

Strategic Capital Foundation
In alignment with this mission, we recently adopted a Bitcoin treasury strategy — a move that reinforces our commitment to sovereignty, self-reliance, and long-term thinking. This has attracted significant international interest and enabled us to secure SEK 53 million convertible loan, with the structure expandable up in total to SEK 298 million. In addition, SEK 10 million is signed in a directed share issue. This capital structure is not only optimized for growth but also resonates deeply with our target shareholders and clients.

Looking Ahead
I firmly believe we are building the foundational infrastructure for the sovereign health economy. I welcome both existing and new shareholders to join us as we scale a global platform purpose-built for those who want to live long — and live free.

Sincerely,
Sander Andersen
CEO, H100 Group AB